全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

奥密克戎全基因序列分段测量可视化分析
Visual Analysis of Whole Gene Sequence Segmentation Measurement in Omicron

DOI: 10.12677/HJCB.2022.123007, PP. 49-57

Keywords: 奥密克戎,分段测量,可视化,Omicron, Segmented Measurement, Visualization

Full-Text   Cite this paper   Add to My Lib

Abstract:

新型冠状病毒在全球范围内爆发以来,先后发生了多次变异。病毒的变异在一定程度上逃避了免疫反应。于2021年南非首次检测到的奥密克戎(Omicron, B.1.1.529)变异株传染率极高,因此也对新型冠状病毒肺炎(COVID-19)的预防和控制带来了更为严峻的挑战。本文将针对奥密克戎全基因序列进行变值测量可视化处理和分析,运用MATLAB软件对其基因序列进行分段测量的可视化展示及分析。可视化展示和分析的结果能够为奥密克戎变异株的进一步研究提供一定的参考。
Since the outbreak of novel coronavirus in the world, there have been many variations. The infection rate of Omicron (B.1.1.529), which was first detected in South Africa in 2021, is extremely high, so it also poses a more severe challenge to the prevention and control of novel coronavirus (COVID-19). In this paper, the whole gene sequence of Omicron will be displayed and analyzed by a visual two-dimensional projection of segmented measurement using MATLAB software. The visualization results show unique graphic features and symmetry, which can provide some reference for further study of Omicron mutant.

References

[1]  洪子强, 盛燕楠, 金大成, 白向豆, 崔百强, 苟云久. 新型冠状病毒Omicron变异株的最新研究进展[J/OL]. 中国热带医学, 1-6. http://kns.cnki.net/kcms/detail/46.1064.r.20220414.1719.002.html, 2022-08-29.
[2]  李静梅, 陈心足. 冠状病毒的基因组结构及特征[J]. 基因组学与应用生物学, 2021, 40(4): 1915-1920.
[3]  解有成, 康殷楠, 高春, 刘珊山, 郑立婷, 于晓辉, 张久聪. 新冠病毒“奥密克戎亚型变异毒株BA.2”的最新研究进展[J]. 海南医学院学报, 2022, 28(8): 561-565.
[4]  完竹, 郑智捷. DNA序列一维分段测量分布可视化[J]. 云南大学学报(自然科学版), 2013(35): 1-6.
[5]  郑智捷. 变值体系理论及其应用第1卷理论基础及其应用[M]. 北京: 科学出版社, 2021: 127-133.
[6]  Zheng, J. and Zhu, M.H. (2021) Input-Output Types of Fifteen Modules on Discrete and Real Measure-ments for COVID-19. EC Neurology, SI. 02, 71-85.
https://doi.org/10.21203/rs.3.rs-65158/v2
[7]  Zhu, M.H. and Zheng, J. (2021) Visual Representation of SARS-CoV-2 Genomes in Multiple Regions on Integrated Maps. EC Neu-rology, SI. 02, 117-131.
[8]  https://www.ncbi.nlm.nih.gov/

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133